CMPS

Compass Pathways PLC

Price

$8.60

return (12m)

29.71%

p/e

-3.91

p/bv

18.23

DIVIDEND YIELD

0.00%

CMPS price

Compass Pathways

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment CMPS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-25.77%

3 months

-36.46%

1 year

29.71%

2 years

83.76%

5 years

-82.43%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CMPS

Valuation

P/E

-3.91

Sector -3.16

Industry -3.16

P/BV

18.23

Sector 1.80

Industry 1.80

P/Revenue (PSR)

Sector 2.04

Industry 2.04

EV/EBITDA

-2.99

Sector -204.34

Industry -204.34

EV/EBIT

-2.99

Sector -42.58

Industry -42.58

P/EBITDA

-3.98

Sector -19.73

Industry -19.73

P/EBIT

-3.98

Sector -67.09

Industry -67.09

P/Total Assets

3.05

Sector 1.06

Industry 1.06

P/Net Current Assets

27.69

Sector -9.56

Industry -9.56

P/Working Capital

14.22

Sector -93.82

Industry -93.82

EPS

-2.92

Sector -1.78

Industry -1.78

BVPS

0.63

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

0.00%

Sector 41.28%

Industry 41.28%

EBITDA Margin

Sector -21,198.78%

Industry -21,198.78%

EBIT Margin

0.00%

Sector -35.28%

Industry -35.28%

Net Profit Margins

0.00%

Sector -35.71%

Industry -35.71%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-319.07%

Sector -61.32%

Industry -61.32%

ROA

-98.78%

Sector -54.29%

Industry -54.29%

ROIC

-79.54%

Sector -1,801.33%

Industry -1,801.33%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.30

Sector 2.91

Industry 2.91

Net Debt / EBITDA

0.99

Sector -20.38

Industry -20.38

Net Debt / EBIT

0.99

Sector -4.13

Industry -4.13

Net Debt / Equity

-4.53

Sector -33,112.98

Industry -33,112.98

Gross Debt / Equity

0.60

Sector -0.64

Industry -0.64

Equity/Assets

0.17

Sector 0.46

Industry 0.46

Liabilities/Assets

0.83

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

40.60%

Sector -

Industry -

Fundamentals CMPS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CMPS Compass Pathways PLC	$8.60	44.54%	0.00%	-3.91	18.23	-319.07%	0.00%
PFE Pfizer Inc.	$30.79	37.60%	5.73%	39.46	2.00	4.97%	6.80%
ABBV AbbVie Inc.	$294.83	40.92%	2.31%	53.66	0.00	-%	14.76%
NVO Novo Nordisk A/S	$42.18	-8.62%	4.66%	9.73	5.17	60.28%	35.32%
MRK Merck & Co. Inc.	$150.36	87.62%	2.27%	116.34	8.79	6.97%	4.77%
AZN AstraZeneca PLC	$189.01	18.47%	1.73%	22.38	5.77	27.27%	16.95%
BMY Bristol-Myers Squibb Company	$64.19	45.68%	5.06%	13.78	5.44	44.06%	18.47%
ZTS Zoetis Inc.	$89.20	-37.02%	2.60%	12.71	10.64	64.91%	27.69%
AMGN Amgen Inc.	$478.48	66.83%	2.13%	28.86	21.58	91.47%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$930.67	45.04%	0.41%	21.68	2.96	14.04%	27.86%
HALO Halozyme Therapeutics Inc.	$130.34	96.89%	0.00%	37.10	106.90	173.67%	24.86%
MCK McKesson Corporation	$1,069.44	31.01%	0.34%	25.96	-30.85	-168.45%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$549.04	28.88%	0.00%	32.22	7.01	23.54%	35.00%
CAH Cardinal Health Inc.	$261.93	39.00%	0.81%	34.74	-21.86	-63.98%	0.67%
ARGX argenx SE	$931.38	12.72%	0.00%	13.26	-	-%	25.42%
HRMY Harmony Biosciences Holdings Inc.	$34.42	17.34%	0.00%	12.39	2.25	20.46%	18.88%
BIIB Biogen Inc.	$254.46	68.03%	0.00%	45.08	2.00	4.58%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CMPS - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Compass Pathways

Compass Pathways PLC

Average Investor10 user rating

4.0 (1 people)

United States

6 years

Founded: 2020

2020

Time since IPO - 6 years

62

Employees

Compass Pathways PLC (United States) is listed on the Nasdaq and has a market capitalization of $1.54 billion, with shareholders equity totaling $84.53 million.

The company employs approximately 62 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Compass Pathways PLC reported $- in revenue, generating net income of $-394.19 million.

Key financial metrics include a P/E ratio of -3.91, a price-to-book (P/B) ratio of 18.23, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CMPS.

Market cap

$1.54 billion

Net worth

$84.53 million

$84,533,000.00

Assets

$504.56 million

$504,561,000.00

Total Shares Outstanding

135.04 million

135,039,000

Average Daily Trading Volume

$2.57 million

$2,571,477.94

Sector

Health Care

Industry

Biotechnology

CMPS

CMPS revenue and profits

Financial Results CMPS

DRAG THE FRAME TO SEE MORE DATA

CMPS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$1,069.44 27,29% (12M)

P/E

25.96

0.34%

ROE

-168.45%

P/BV

-30.85

CAH - Cardinal Health

$261.93 34,36% (12M)

P/E

34.74

0.81%

ROE

-63.98%

P/BV

-21.86

ABBV - AbbVie

$294.83 40,35% (12M)

P/E

53.66

2.31%

ROE

P/BV

0.00

MRK - Merck & Co.

$150.36 83,40% (12M)

P/E

116.34

2.27%

ROE

6.97%

P/BV

8.79

AZN - AstraZeneca

$189.01 14,76% (12M)

P/E

22.38

1.73%

ROE

27.27%

P/BV

5.77

PFE - Pfizer

$30.79 35,87% (12M)

P/E

39.46

5.73%

ROE

4.97%

P/BV

2.00

BMY - Bristol-Myers Squibb

$64.19 44,27% (12M)

P/E

13.78

5.06%

ROE

44.06%

P/BV

5.44

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$1,069.44 27,29% (12 M)

P/L

25.96

0.34%

ROE

-168.45%

P/VP

-30.85

CAH - Cardinal Health

$261.93 34,36% (12 M)

P/L

34.74

0.81%

ROE

-63.98%

P/VP

-21.86

ABBV - AbbVie

$294.83 40,35% (12 M)

P/L

53.66

2.31%

ROE

P/VP

0.00

MRK - Merck & Co.

$150.36 83,40% (12 M)

P/L

116.34

2.27%

ROE

6.97%

P/VP

8.79

AZN - AstraZeneca

$189.01 14,76% (12 M)

P/L

22.38

1.73%

ROE

27.27%

P/VP

5.77

PFE - Pfizer

$30.79 35,87% (12 M)

P/L

39.46

5.73%

ROE

4.97%

P/VP

2.00

BMY - Bristol-Myers Squibb

$64.19 44,27% (12 M)

P/L

13.78

5.06%

ROE

44.06%

P/VP

5.44

Frequently Asked Questions

What is the price of Compass Pathways (CMPS) today?

The current price of Compass Pathways (CMPS) is $8.60. The stock began the year trading around $6.90 and is currently priced at $8.60. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Compass Pathways (CMPS) pay dividends?

Compass Pathways (CMPS) did not pay dividends over the past year.

Is Compass Pathways (CMPS) a good investment?

Compass Pathways (CMPS) is currently trading at $8.60 with a P/E ratio of -3.91. This represents a -337% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 29.71%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Compass Pathways (CMPS) stock?

You can buy Compass Pathways (CMPS) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol CMPS and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Compass Pathways (CMPS) yield today?

Over the past month, Compass Pathways (CMPS) has returned -25.77% — 29.71% over the past year, and -82.43% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Compass Pathways (CMPS) today at the current price of $8.60 your total investment would be $860.00.

Based on historical performance, the investment would have grown to approximately:

$1,115.51 after 1 year
$151.10 after 5 years
$860.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CMPS

Compass Pathways PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CMPS

Target price created!

Delete target price?

Your Target Price strategy deserves unlimited alerts

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING CMPS WITH OTHER STOCKS

ABOUT Compass Pathways

Compass Pathways PLC

United States

6 years

2020

62

PROFIT X PRICE CMPS

Financial Results CMPS

CMPS cash flow

Asset, Revenue and Profit Growth - CMPS

CMPS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions